CMB 0.00% 0.5¢ cambium bio limited

Ann: New CEO Appointed to Accelerate Global Growth, page-22

  1. 430 Posts.
    lightbulb Created with Sketch. 225
    Bio, I share your view about Sygenus potential.
    It would be good if we could get a status report on where things are up to with:
    - commercialising the acne treatment;
    - the Adelaide Uni/Macquarie Uni follow up to the Israeli study findings on use of Sygenus for pain management;
    - current and planned studies into use of Sygenus for other specific medical/dermatological conditions.

    i can’t see that there would be a commercial need for the company to be a secret squirrel about any of those 3 things.

    zeno9 
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $3.83M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $125 25K

Buyers (Bids)

No. Vol. Price($)
3 243821 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 502179 4
View Market Depth
Last trade - 14.51pm 21/06/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.